AKLI Stock Summary and Trading Ideas (Akili | NASDAQ:AKLI)

Akili Inc is a digital medicine company pioneering the development of cognitive treatments through game-changing technologies.

Akili trades on the NASDAQ stock market under the symbol AKLI.

As of April 22, 2024, AKLI stock price declined to $0.23 with 64,704 million shares trading.

AKLI has a beta of 1.23, meaning it tends to be more sensitive to market movements. AKLI has a correlation of 0.02 to the broad based SPY ETF.

AKLI has a market cap of $17.94 million. This is considered a Sub-Micro Cap stock.

Last quarter Akili reported $749,000 in Revenue and -$.14 earnings per share. This fell short of revenue expectation by $-51,000 and exceeded earnings estimates by $.07.

The top ETF exchange traded funds that AKLI belongs to (by Net Assets): VXF, IWC.

AKLI has underperformed the market in the last year with a price return of -81.2% while the SPY ETF gained +22.9%. AKLI has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -24.6% and -11.7%, respectively, while the SPY returned +3.7% and -3.7%, respectively.

AKLI support price is $.22 and resistance is $.26 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AKLI stock will trade within this expected range on the day.